|
"lee ty"的相關文件
顯示項目 1-25 / 95 (共4頁) 1 2 3 4 > >> 每頁顯示[10|25|50]項目
國家衛生研究院 |
2024-03-15 |
Epstein-barr virus BRLF1 induces PD-L1 expression in nasopharyngeal carcinoma cells
|
Wu, CC;Chen, MS;Lee, TY;Huang, TS;Cho, DY;Chen, JY |
國家衛生研究院 |
2024-01 |
Diet supplementation with prinsepiae nux extract in broiler chickens: Its effect on growth performance and expression of antioxidant, Pro-inflammatory, and heat shock protein genes
|
Tran, HL;Chen, YS;Hung, HW;Shih, BL;Lee, TY;Yen, CH;Lin, JB |
國家衛生研究院 |
2023-07-13 |
Screening and identification of emodin as an EBV DNase inhibitor to prevent its biological functions
|
Wu, CC;Chen, MS;Lee, TY;Cheng, YJ;Tsou, HH;Huang, TS;Cho, DY;Chen, JY |
國家衛生研究院 |
2023-07 |
Daily aspirin associated with a reduced risk of hepatocellular carcinoma in patients with non-alcoholic fatty liver disease: a population-based cohort study
|
Lee, TY;Hsu, YC;Ho, HJ;Lin, JT;Chen, YJ;Wu, CY |
國家衛生研究院 |
2023-06-21 |
Severe hepatitis B flares with hepatic decompensation after withdrawal of nucleos(t)ide analogues: A population-based cohort study
|
Hsu, YC;Lin, YH;Lee, TY;Nguyen, MH;Tseng, CH;Ho, HJ;Kao, FY;Lin, JT;Wu, CY;Wu, CY |
國家衛生研究院 |
2023-06 |
Atezolizumab plus bevacizumab for patients with unresectable hepatocellular carcinoma and high hepatitis B viral load: Focusing on hepatic safety and viral kinetics
|
Chen, SC;Tsou, HHS;Lee, TY;Wang, HW;Chen, YH;Wang, TE;Su, YY;Yang, S;Chiu, CF;Liu, TW;Cheng, AL;Chen, LT;Hsu, C |
國家衛生研究院 |
2022-12-23 |
The dietary flavonol kaempferol inhibits epstein-barr virus reactivation in nasopharyngeal carcinoma cells
|
Wu, CC;Lee, TY;Cheng, YJ;Cho, DY;Chen, JY |
中山醫學大學 |
2021 |
Liver Injury in Liver Transplant Patients With COVID-19: A Histopathologic Analysis Reply
|
Lee, TY; Wu, CY |
中山醫學大學 |
2021 |
Long-Term Safety in HBsAg-Negative, HBcAb-Positive Patients with Rheumatic Diseases Receiving Maintained Steroid Therapy after Pulse Therapy
|
Lin, YC; Chen, YJ; Lee, SW; Lee, TY; Chen, YH; Huang, WN; Yang, SS; Chen, YM |
中山醫學大學 |
2021 |
Advances in the Era of Direct-Acting Antivirals for Hepatitis C in Patients with Unresectable Hepatocellular Carcinoma
|
Chen, LS; Lee, SW; Yang, SS; Tsai, HJ; Lee, TY |
中山醫學大學 |
2021 |
Establishing the blood reference interval of pancreatic elastase-1: A prospective study
|
Chi, SF; Lai, CY; Dong, WT; Wang, JM; Wang, YY; Yang, SS; Lin, JT; Lee, TY |
中山醫學大學 |
2021 |
The correlation with tumor radiological characteristics and prognosis of patients with early-stage hepatocellular carcinoma receiving transcatheter arterial chemoembolization
|
Lee, SW; Lee, TY; Cheng, YC; Yen, CL; Yang, SS |
中山醫學大學 |
2021 |
Once-daily tenofovir disoproxil fumarate in treatment-naive Taiwanese patients with chronic hepatitis B and minimally raised alanine aminotransferase (TORCH-B): a multicentre, double-blind, placebo-controlled, parallel-group, randomised trial
|
Hsu, YC; Chen, CY; Chang, IW; Chang, CY; Wu, CY; Lee, TY; Wu, MS; Bair, MJ; Chen, JJ; Chen, CC; Tseng, CH; Tai, CM; Huang, YT; Ku, WH; Mo, LR; Lin, JT |
中山醫學大學 |
2021 |
Evaluating the renal safety of tenofovir disoproxil fumarate in hepatitis B patients without chronic kidney disease
|
Tsai, HJ; Chuang, YW; Yang, SS; Chang, YZ; Chang, HR; Lee, TY |
中山醫學大學 |
2021 |
Cessation of Nucleos(t)ide Analogue Therapy in Non-Cirrhotic Hepatitis B Patients with Prior Severe Acute Exacerbation
|
Lai, CY; Yang, SS; Lee, SW; Tsai, HJ; Lee, TY |
國家衛生研究院 |
2020-04-28 |
Association of daily Aspirin therapy with Hepatocellular Carcinoma risk in patients with chronic Hepatitis C Virus infection
|
Lee, TY;Hsu, YC;Tseng, HC;Lin, JT;Wu, MS;Wu, CY |
國家衛生研究院 |
2020-03-30 |
Atorvastatin-induced senescence of hepatocellular carcinoma is mediated by downregulation of hTERT through the suppression of the IL-6/STAT3 pathway
|
Wang, ST;Huang, SW;Liu, KT;Lee, TY;Shieh, JJ;Wu, CY |
國家衛生研究院 |
2020-03-30 |
Atorvastatin-induced senescence of hepatocellular carcinoma is mediated by downregulation of hTERT through the suppression of the IL-6/STAT3 pathway
|
Wang, ST;Huang, SW;Liu, KT;Lee, TY;Shieh, JJ;Wu, CY |
中山醫學大學 |
2020 |
The therapeutic benefits of combined sorafenib and transarterial chemoembolization for advanced hepatocellular carcinoma
|
Lee, SW; Lee, TY; Peng, YC; Yang, SS; Yeh, HZ; Chang, CS |
中山醫學大學 |
2020 |
Atorvastatin-induced senescence of hepatocellular carcinoma is mediated by downregulation of hTERT through the suppression of the IL-6/STAT3 pathway
|
Wang, ST; Huang, SW; Liu, KT; Lee, TY; Shieh, JJ; Wu, CY |
中山醫學大學 |
2020 |
Association of Daily Aspirin Therapy With Hepatocellular Carcinoma Risk in Patients With Chronic Hepatitis C Virus Infection
|
Lee, TY; Hsu, YC; Tseng, HC; Lin, JT; Wu, MS; Wu, CY |
中山醫學大學 |
2020 |
ALT Levels for Asians With Metabolic Diseases: A Meta-analysis of 86 Studies With Individual Patient Data Validation
|
Huang, DQ; Yeo, YH; Tan, E; Takahashi, H; Yasuda, S; Saruwatari, J; Tanaka, K; Oniki, K; Kam, LY; Muthiah, MD; Hyogo, H; Ono, M; Barnett, SD; Li, J; Zou, BY; Fung, J; Lee, TY; Wong, VWS; Yuen, MF; Dan, YY; Lim, SG; Cheung, R; Toyoda, H; Eguchi, Y; Nguyen, MH |
中山醫學大學 |
2020 |
Hepatitis B flare during osimertinib targeted therapy in a lung cancer patient with a resolved hepatitis B virus infection
|
Lee, PH; Lee, TY; Chang, GC |
中山醫學大學 |
2020 |
Impact of Glutathione and Vitamin B-6 in Cirrhosis Patients: A Randomized Controlled Trial and Follow-Up Study
|
Lai, CY; Cheng, SB; Lee, TY; Hsiao, YF; Liu, HT; Huang, YC |
國立交通大學 |
2019-04-02T05:58:40Z |
Electrooptical properties of an aligned phase-change guest-host mode liquid crystal display
|
Wu, JJ; Lee, TY; Chen, SH; Kuo, CL |
顯示項目 1-25 / 95 (共4頁) 1 2 3 4 > >> 每頁顯示[10|25|50]項目
|